The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Heat Shock Proteins 70 and 90 Inhibit Early Stages of Amyloid β-(1–42) Aggregation in Vitro
Open accessAbstract
Alzheimer disease is a neurological disorder that is characterized by the presence of fibrils and oligomers composed of the amyloid beta (Abeta) peptide. In models of Alzheimer disease, overexpression of molecular chaperones, specifically heat shock protein 70 (Hsp70), suppresses phenotypes related to Abeta aggregation. These observations led to the hypothesis that chaperones might interact with Abeta and block self-association. However, although biochemical evidence to support this model has been collected in other neurodegenerative systems, the interaction between chaperones and Abeta has not been similarly explored. Here, we examine the effects of Hsp70/40 and Hsp90 on Abeta aggregation in vitro. We found that recombinant Hsp70/40 and Hsp90 block Abeta self-assembly and that these chaperones are effective at substoichiometric concentrations (approximately 1:50). The anti-aggregation activity of Hsp70 can be inhibited by a nonhydrolyzable nucleotide analog and encouraged by pharmacological stimulation of its ATPase activity. Finally, we were interested in discerning what type of amyloid structures can be acted upon by these chaperones. To address this question, we added Hsp70/40 and Hsp90 to pre-formed oligomers and fibrils. Based on thioflavin T reactivity, the combination of Hsp70/40 and Hsp90 caused structural changes in oligomers but had little effect on fibrils. These results suggest that if these chaperones are present in the same cellular compartment in which Abeta is produced, Hsp70/40 and Hsp90 may suppress the early stages of self-assembly. Thus, these results are consistent with a model in which pharmacological activation of chaperones might have a favorable therapeutic effect on Alzheimer disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769
RetractedWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Molecular chaperones in cellular protein folding
Hartl, F. U. (1996) · Nature · doi:10.1038/381571a0 · Cited by 3,568
Pathways towards and Away from Alzheimer’s Disease
Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052
The Hsp70 and Hsp60 Chaperone Machines
Bukau, B., & Horwich, A. L. (1998) · Cell · doi:10.1016/s0092-8674(00)80928-9 · Cited by 2,815
Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective
Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849
Caughey, B., & Lansbury, P. T. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.010302.081142 · Cited by 1,650
Molecular Chaperones and Protein Quality Control
Bukau, B., Weissman, J., & Horwich, A. (2006) · Cell · doi:10.1016/j.cell.2006.04.014 · Cited by 1,557
Pratt, W. B., & Toft, D. O. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800201 · Cited by 1,483
Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability
Dahlgren, K. N., Manelli, A. M., Stine, W. B., Baker, L. K., Krafft, G. A., & LaDu, M. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201750200 · Cited by 1,452
Folding proteins in fatal ways
Selkoe, D. J. (2003) · Nature · doi:10.1038/nature02264 · Cited by 1,417
Glover, J. R., & Lindquist, S. (1998) · Cell · doi:10.1016/s0092-8674(00)81223-4 · Cited by 1,357
Gong, Y., Chang, L., Viola, K. L., Lacor, P. N., Lambert, M. P., Finch, C. E., Krafft, G. A., & Klein, W. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834302100 · Cited by 1,061
In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis
Stine, W. B., Dahlgren, K. N., Krafft, G. A., & LaDu, M. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210207200 · Cited by 1,015
Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.
Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C., & Glabe, C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48529-8 · Cited by 1,014
Warrick, J. M., Chan, H. Y. E., Gray-Board, G. L., Chai, Y., Paulson, H. L., & Bonini, N. M. (1999) · Nature Genetics · doi:10.1038/70532 · Cited by 830
Leissring, M. A., Farris, W., Chang, A. Y., Walsh, D. M., Wu, X., Sun, X., Frosch, M. P., & Selkoe, D. J. (2003) · Neuron · doi:10.1016/s0896-6273(03)00787-6 · Cited by 719
Amyloid diseases: Abnormal protein aggregation in neurodegeneration
Koo, E. H., Lansbury, P. T., & Kelly, J. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.9989 · Cited by 693
Muchowski, P. J., Schaffar, G., Sittler, A., Wanker, E. E., Hayer-Hartl, M. K., & Hartl, F. U. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.140202897 · Cited by 667
Progressive disruption of cellular protein folding in models of polyglutamine diseases
Gidalevitz, T., Ben-Zvi, A., Ho, K. H., Brignull, H. R., & Morimoto, R. I. (2006) · Science · doi:10.1126/science.1124514 · Cited by 643
Townsend, M., Shankar, G. M., Mehta, T., Walsh, D. M., & Selkoe, D. J. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2005.103754 · Cited by 619
Common mechanisms of amyloid oligomer pathogenesis in degenerative disease
Glabe, C. G. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.04.017 · Cited by 569
Self-Assembly of Aβ 1 - 42 into Globular Neurotoxins
Chromy, B. A., Nowak, R. J., Lambert, M. P., Viola, K. L., Chang, L., Velasco, P. T., Jones, B. W., Fernandez, S. J., Lacor, P. N., Horowitz, P., et al. (2003) · Biochemistry · doi:10.1021/bi030029q · Cited by 522
Hsp70 Reduces α-Synuclein Aggregation and Toxicity
Klucken, J., Shin, Y., Masliah, E., Hyman, B. T., & McLean, P. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400255200 · Cited by 508
Vekrellis, K., Ye, Z., Qiu, W. Q., Walsh, D., Hartley, D., Chesneau, V., Rosner, M. R., & Selkoe, D. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-05-01657.2000 · Cited by 495
Cummings, C. J. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.14.1511 · Cited by 485
Heat Shock Response Modulators as Therapeutic Tools for Diseases of Protein Conformation
Westerheide, S. D., & Morimoto, R. I. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.r500010200 · Cited by 481
Hsp104 Catalyzes Formation and Elimination of Self-Replicating Sup35 Prion Conformers
Shorter, J., & Lindquist, S. (2004) · Science · doi:10.1126/science.1098007 · Cited by 463
Oligomerization of Alzheimer's β-Amyloid within Processes and Synapses of Cultured Neurons and Brain
Takahashi, R. H., Almeida, C. G., Kearney, P. F., Yu, F., Lin, M. T., Milner, T. A., & Gouras, G. K. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5167-03.2004 · Cited by 445
Oligomers on the Brain: the Emerging Role of Soluble Protein Aggregates in Neurodegeneration.
Walsh, D., & Selkoe, D. (2004) · Protein & Peptide Letters · doi:10.2174/0929866043407174 · Cited by 428
Celastrols as Inducers of the Heat Shock Response and Cytoprotection
Westerheide, S. D., Bosman, J. D., Mbadugha, B. N. A., Kawahara, T. L. A., Matsumoto, G., Kim, S., Gu, W., Devlin, J. P., Silverman, R. B., & Morimoto, R. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409267200 · Cited by 427
Yeast Genes That Enhance the Toxicity of a Mutant Huntingtin Fragment or α-Synuclein
Willingham, S., Outeiro, T. F., DeVit, M. J., Lindquist, S. L., & Muchowski, P. J. (2003) · Science · doi:10.1126/science.1090389 · Cited by 422
17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration
Waza, M., Adachi, H., Katsuno, M., Minamiyama, M., Sang, C., Tanaka, F., Inukai, A., Doyu, M., & Sobue, G. (2005) · Nature Medicine · doi:10.1038/nm1298 · Cited by 395
Du Yan, S., Fu, J., Soto, C., Chen, X., Zhu, H., Al-Mohanna, F., Collison, K., Zhu, A., Stern, E., Saido, T., et al. (1997) · Nature · doi:10.1038/39522 · Cited by 379
Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans
Satyal, S. H., Schmidt, E., Kitagawa, K., Sondheimer, N., Lindquist, S., Kramer, J. M., & Morimoto, R. I. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100107297 · Cited by 371
Hay, D. G. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh144 · Cited by 327
Regulation of the Heat-shock Protein 70 Reaction Cycle by the Mammalian DnaJ Homolog, Hsp40
Minami, Y., Höhfeld, J., Ohtsuka, K., & Hartl, F.-U. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19617 · Cited by 323
Soto, C., Castaño, E. M., Frangione, B., & Inestrosa, N. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.7.3063 · Cited by 321
Structure and in vivo function of Hsp90
Pearl, L. H., & Prodromou, C. (2000) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(99)00047-0 · Cited by 317
Pollard, T. D., & Mooseker, M. S. (1981) · The Journal of cell biology · doi:10.1083/jcb.88.3.654 · Cited by 306
Roles of molecular chaperones in protein misfolding diseases
Barral, J. M., Broadley, S. A., Schaffar, G., & Hartl, F. U. (2004) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2003.12.010 · Cited by 295
Wacker, J. L., Zareie, M. H., Fong, H., Sarikaya, M., & Muchowski, P. J. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb860 · Cited by 283
De Los Rios, P., Ben-Zvi, A., Slutsky, O., Azem, A., & Goloubinoff, P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510496103 · Cited by 267
Fezoui, Y., Hartley, D. M., Harper, J. D., Khurana, R., Walsh, D. M., Condron, M. M., Selkoe, D. J., Lansbury, P. T., Fink, A. L., & Teplow, D. B. (2000) · Amyloid · doi:10.3109/13506120009146831 · Cited by 260
Magrané, J., Smith, R. C., Walsh, K., & Querfurth, H. W. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4330-03.2004 · Cited by 242
Population-based case-control study of cognitive function in essential tremor
Benito-León, J., Louis, E. D., & Bermejo-Pareja, F. (2006) · Neurology · doi:10.1212/01.wnl.0000192393.05850.ec · Cited by 241
Katsuno, M., Sang, C., Adachi, H., Minamiyama, M., Waza, M., Tanaka, F., Doyu, M., & Sobue, G. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506249102 · Cited by 237
Dedmon, M. M., Christodoulou, J., Wilson, M. R., & Dobson, C. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413024200 · Cited by 235
Size-dependent Disaggregation of Stable Protein Aggregates by the DnaK Chaperone Machinery
Diamant, S., Ben-Zvi, A. P., Bukau, B., & Goloubinoff, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001293200 · Cited by 230
A Strategy for Designing Inhibitors of β-Amyloid Toxicity
Ghanta, J., Shen, C.-L., Kiessling, L. L., & Murphy, R. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.47.29525 · Cited by 226
Lowe, T. L., Strzelec, A., Kiessling, L. L., & Murphy, R. M. (2001) · Biochemistry · doi:10.1021/bi002734u · Cited by 225
Small Molecule Modulators of Endogenous and Co-chaperone-stimulated Hsp70 ATPase Activity
Fewell, S. W., Smith, C. M., Lyon, M. A., Dumitrescu, T. P., Wipf, P., Day, B. W., & Brodsky, J. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404857200 · Cited by 211
Interaction of intracellular β amyloid peptide with chaperone proteins
Fonte, V., Kapulkin, W. J., Taft, A., Fluet, A., Friedman, D., & Link, C. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152313999 · Cited by 211
Alzheimer Disease: Mechanistic Understanding Predicts Novel Therapies
Selkoe, D. J. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-8-200404200-00047 · Cited by 208
Harnessing Chaperones to Generate Small-Molecule Inhibitors of Amyloid ß Aggregation
Gestwicki, J. E., Crabtree, G. R., & Graef, I. A. (2004) · Science · doi:10.1126/science.1101262 · Cited by 200
Self-citationBrendza, R. P., Bacskai, B. J., Cirrito, J. R., Simmons, K. A., Skoch, J. M., Klunk, W. E., Mathis, C. A., Bales, K. R., Paul, S. M., Hyman, B. T., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23269 · Cited by 190
Kienlen-Campard, P., Miolet, S., Tasiaux, B., & Octave, J.-N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200887200 · Cited by 187
Structural insights into substrate binding by the molecular chaperone DnaK.
Gierasch, L. M., Zuiderweg, E. R. P., Pellecchia, M., Montgomery, D. L., Stevens, S. Y., Kooi, C. W. V., & Feng, H.-P. (2000) · Nature Structural Biology · doi:10.1038/74062 · Cited by 187
Amyloidogenic processing of β-amyloid precursor protein in intracellular compartments
Vetrivel, K. S., & Thinakaran, G. (2006) · Neurology · doi:10.1212/01.wnl.0000192107.17175.39 · Cited by 177
Geldanamycin induces Hsp70 and prevents α-synuclein aggregation and toxicity in vitro
McLean, P. J., Klucken, J., Shin, Y., & Hyman, B. T. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.021 · Cited by 177
The Amyloid β Peptide (Aβ1-40) Is Thermodynamically Soluble at Physiological Concentrations
Sengupta, P., Garai, K., Sahoo, B., Shi, Y., Callaway, D. J. E., & Maiti, S. (2003) · Biochemistry · doi:10.1021/bi0341410 · Cited by 167
Substrate Transfer from the Chaperone Hsp70 to Hsp90
Wegele, H., Wandinger, S. K., Schmid, A. B., Reinstein, J., & Buchner, J. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.12.008 · Cited by 162
Tienari, P. J., Ida, N., Ikonen, E., Simons, M., Weidemann, A., Multhaup, G., Masters, C. L., Dotti, C. G., & Beyreuther, K. T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4125 · Cited by 155
Raman, B., Ban, T., Sakai, M., Pasta, S. Y., Ramakrishna, T., Naiki, H., Goto, Y., & Rao, C. M. (2005) · Biochemical Journal · doi:10.1042/bj20050339 · Cited by 148
In Vitro Growth of Alzheimer's Disease β-Amyloid Plaques Displays First-Order Kinetics †
Esler, W. P., Stimson, E. R., Ghilardi, J. R., Vinters, H. V., Lee, J. P., Mantyh, P. W., & Maggio, J. E. (1996) · Biochemistry · doi:10.1021/bi951685w · Cited by 128
Magrané, J., Rosen, K. M., Smith, R. C., Walsh, K. X., Gouras, G. K., & Querfurth, H. W. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1723-05.2005 · Cited by 126
Martin, B. L., Schrader‐Fischer, G., Busciglio, J. A., Duke, M., Paganetti, P., & Yankner, B. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26727 · Cited by 119
Aisen, P. S. S. (2005) · CNS Drugs · doi:10.2165/00023210-200519120-00002 · Cited by 113
The Role of Amyloid-Beta Derived Diffusible Ligands (ADDLs) in Alzheimers Disease
Catalano, S. M., Dodson, E., Henze, D. A., Joyce, J. G., Krafft, G. A., & Kinney, G. G. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606776743066 · Cited by 107
Tabaton, M., Cammarata, S., Mancardi, G., Manetto, V., AUTILIO‐GAMBETTI, L., Perry, G. L., & Gambetti, P. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2098 · Cited by 99
Fuller, S. J., Storey, E., Li, Q.-X., Smith, A. I., Beyreuther, K., & Masters, C. L. (1995) · Biochemistry · doi:10.1021/bi00025a015 · Cited by 92
Peptide Inhibitors of Beta Amyloid Aggregation
Findeis, M. A. (2002) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026024607508 · Cited by 90
Hama, E., Shirotani, K., Masumoto, H., Sekine‐Aizawa, Y., Aizawa, H., & Saido, T. C. (2001) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a003040 · Cited by 86
Progress and problems in the biology, diagnostics, and therapeutics of prion diseases
Aguzzi, A., Heikenwälder, M. F., & Miele, G. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22438 · Cited by 73
Hsp20, a novel α‐crystallin, prevents Aβ fibril formation and toxicity
Lee, S., Carson, K. H., Rice‐Ficht, A. C., & Good, T. A. (2005) · Protein Science · doi:10.1110/ps.041020705 · Cited by 72
Identification of an Inhibitor of hsc70-mediated Protein Translocation and ATP Hydrolysis
Fewell, S. W., Day, B. W., & Brodsky, J. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008535200 · Cited by 66
Dul, J. L., Davis, D. P., Williamson, E. K., Stevens, F. J., & Argon, Y. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.4.705 · Cited by 66
Human β-secretase (BACE) and BACE Inhibitors: Progress Report
John, V. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606776743084 · Cited by 61
Bohrmann, B., Adrian, M., Dubochet, J., Kuner, P., Müller, F., Huber, W., Nordstedt, C., & Döbeli, H. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4241 · Cited by 58
Grant, S. M., Ducatenzeiler, A., Moshe Szyf, A., & Cuello, A. C. (2000) · Journal of Alzheimer s Disease · doi:10.3233/jad-2000-23-403 · Cited by 54
Pangalos, M. N., Jacobsen, S. J., & Reinhart, P. H. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330553 · Cited by 52
Inhibitors and Modulators of β- and γ-Secretase
Schmidt, B., Baumann, S., Braun, H., et al. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606776287027 · Cited by 48
Selectivity of the molecular chaperone-specific immunosuppressive agent 15-deoxyspergualin
Brodsky, J. L. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00376-1 · Cited by 46
[29] Screening for pharmacologic inhibitors of amyloid fibril formation
LeVine, H., & Scholten, J. D. (1999) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(99)09031-x · Cited by 43
Bistability Explains Threshold Phenomena in Protein Aggregation both In Vitro and In Vivo
Rieger, T. R., Morimoto, R. I., & Vassily Hatzimanikatis, A. (2005) · Biophysical Journal · doi:10.1529/biophysj.105.066662 · Cited by 28
Morelli, L., Llovera, R. E., Ibendahl, S., & Castaño, E. M. (2002) · Neurochemical Research · doi:10.1023/a:1021679817756 · Cited by 27
Matsumoto, A., & Matsumoto, R. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.1055b.x · Cited by 20
Cited by
Schopf, F. H., Biebl, M. M., & Buchner, J. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.20 · Cited by 1,540
The HSP90 Family: Structure, Regulation, Function, and Implications in Health and Disease
Hoter, A., El-Sabban, M. E., & Naim, H. Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092560 · Cited by 693
Targeting heat shock proteins in cancer
Jego, G., Hazoumé, A., Seigneuric, R., & Garrido, C. (2013) · Cancer Letters · doi:10.1016/j.canlet.2010.10.014 · Cited by 452
Heat Shock Protein 70 (Hsp70) as an Emerging Drug Target
Evans, C. G., Chang, L., & Gestwicki, J. E. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100054f · Cited by 436
Self-citationHSPA8/HSC70 chaperone protein: Structure, function, and chemical targeting
Stricher, F., Macri, C., Ruff, M., & Muller, S. (2013) · Autophagy · doi:10.4161/auto.26448 · Cited by 418
Metadata
- Authors
- Evans, C. G., Wisén, S., & Gestwicki, J. E.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-11
- Volume
- 281
- Issue
- 44
- Pages
- 33182-33191
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2148026632
- Cited by
- 382
- References
- 87
- FWCI
- 9.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.